MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma.
Masih-Khan E, Trudel S, Heise C, Li Z, Paterson J, Nadeem V, Wei E, Roodman D, Claudio JO, Bergsagel PL, Stewart AK.
Masih-Khan E, et al. Among authors: trudel s.
Blood. 2006 Nov 15;108(10):3465-71. doi: 10.1182/blood-2006-04-017087. Epub 2006 Jul 18.
Blood. 2006.
PMID: 16849642
Free article.